CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT

The purpose of the present work was to study the clinical features and risk factors of tardive dyskinesia among     the     schizophrenia     patients     who     durably     receive     the     antipsychotic     therapy. 180 of the 18 to 65 age bracket schizophrenia patients, who were treated in a...

Full description

Bibliographic Details
Main Authors: Ye. G. Kornetova, A. V. Semke, Ye. G. Dmitrieva, Yu. N. Borodyuk, A. S. Boyko
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2015-02-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/111
_version_ 1797872935532232704
author Ye. G. Kornetova
A. V. Semke
Ye. G. Dmitrieva
Yu. N. Borodyuk
A. S. Boyko
author_facet Ye. G. Kornetova
A. V. Semke
Ye. G. Dmitrieva
Yu. N. Borodyuk
A. S. Boyko
author_sort Ye. G. Kornetova
collection DOAJ
description The purpose of the present work was to study the clinical features and risk factors of tardive dyskinesia among     the     schizophrenia     patients     who     durably     receive     the     antipsychotic     therapy. 180 of the 18 to 65 age bracket schizophrenia patients, who were treated in a residential psychiatric treatment facility, were examined with the use of the Positive and Negative Syndrome Scale (PANSS), Abnormal Involuntary Movement Scale (AIMS), and the basic chart of formalized sociodemographic and clinico-dynamic features developed at the Tomsk Mental Health Research Institute. The acquired data were processed by the Mann–Whitney U-Test and χ2. The average age of the tardive dyskinesia patients  turned out to be conclusively older than that of the patients without this derangement. People who have tardive dyskinesia statistically often happen to be single in comparison with other variants of marital status. It was found out that women happen to have tardive dyskinesia more often, which allows us to see the female gender as a risk factor. The tardive dyskinesia patients had certain negative symptoms. The patients were arranged into groups according to the prepotency of symptom-complexes over the subgroups: with orofacial, thoracolumbar and combined tardive dyskinesia. The average age of the orofacial dyskinesia patients turned out to be conclusively older than that of the patients without tardive dyskinesia. The negative symptoms level in the subgroup was conclusively higher than among those without tardive dyskinesia. The average age of the thoracolumbar dyskinesia patients was conclusively older than that of the patients without tardive dyskinesia. The average age of the combined dyskinesia patients was conclusively older than the patients without the tardive dyskinesia. The patients having schizophrenia for longer than 10 years prevailed in the combined dyskinesia group. Such characteristics as education level and social status, age of when the medical problem started, dominance of the positive symptoms, duration of antipsychotic agents administration, somatic condition, use of psychoactive substances, suicidal and hetero-aggressive behaviors make no contribution to the risk of tardive dyskinesia development in the presence of schizophrenia, and they are not protective factors either.
first_indexed 2024-04-10T01:08:08Z
format Article
id doaj.art-ecac4bb458cb425f85b117ed95c319af
institution Directory Open Access Journal
issn 1682-0363
1819-3684
language English
last_indexed 2024-04-10T01:08:08Z
publishDate 2015-02-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj.art-ecac4bb458cb425f85b117ed95c319af2023-03-13T09:58:21ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842015-02-01141323910.20538/1682-0363-2015-1-32-39109CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENTYe. G. Kornetova0A. V. Semke1Ye. G. Dmitrieva2Yu. N. Borodyuk3A. S. Boyko4Научно-исследовательский институт психического здоровья, ТомскНаучно-исследовательский институт психического здоровья, ТомскНаучно-исследовательский институт психического здоровья, ТомскНаучно-исследовательский институт психического здоровья, ТомскНаучно-исследовательский институт психического здоровья, ТомскThe purpose of the present work was to study the clinical features and risk factors of tardive dyskinesia among     the     schizophrenia     patients     who     durably     receive     the     antipsychotic     therapy. 180 of the 18 to 65 age bracket schizophrenia patients, who were treated in a residential psychiatric treatment facility, were examined with the use of the Positive and Negative Syndrome Scale (PANSS), Abnormal Involuntary Movement Scale (AIMS), and the basic chart of formalized sociodemographic and clinico-dynamic features developed at the Tomsk Mental Health Research Institute. The acquired data were processed by the Mann–Whitney U-Test and χ2. The average age of the tardive dyskinesia patients  turned out to be conclusively older than that of the patients without this derangement. People who have tardive dyskinesia statistically often happen to be single in comparison with other variants of marital status. It was found out that women happen to have tardive dyskinesia more often, which allows us to see the female gender as a risk factor. The tardive dyskinesia patients had certain negative symptoms. The patients were arranged into groups according to the prepotency of symptom-complexes over the subgroups: with orofacial, thoracolumbar and combined tardive dyskinesia. The average age of the orofacial dyskinesia patients turned out to be conclusively older than that of the patients without tardive dyskinesia. The negative symptoms level in the subgroup was conclusively higher than among those without tardive dyskinesia. The average age of the thoracolumbar dyskinesia patients was conclusively older than that of the patients without tardive dyskinesia. The average age of the combined dyskinesia patients was conclusively older than the patients without the tardive dyskinesia. The patients having schizophrenia for longer than 10 years prevailed in the combined dyskinesia group. Such characteristics as education level and social status, age of when the medical problem started, dominance of the positive symptoms, duration of antipsychotic agents administration, somatic condition, use of psychoactive substances, suicidal and hetero-aggressive behaviors make no contribution to the risk of tardive dyskinesia development in the presence of schizophrenia, and they are not protective factors either.https://bulletin.ssmu.ru/jour/article/view/111шизофренияпсихофармакотерапиятардивная дискинезияантипсихотики
spellingShingle Ye. G. Kornetova
A. V. Semke
Ye. G. Dmitrieva
Yu. N. Borodyuk
A. S. Boyko
CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
Бюллетень сибирской медицины
шизофрения
психофармакотерапия
тардивная дискинезия
антипсихотики
title CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
title_full CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
title_fullStr CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
title_full_unstemmed CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
title_short CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
title_sort clinical and social risk factors of tardive dyskinesia in patients with schizophrenia during antipsychotic treatment
topic шизофрения
психофармакотерапия
тардивная дискинезия
антипсихотики
url https://bulletin.ssmu.ru/jour/article/view/111
work_keys_str_mv AT yegkornetova clinicalandsocialriskfactorsoftardivedyskinesiainpatientswithschizophreniaduringantipsychotictreatment
AT avsemke clinicalandsocialriskfactorsoftardivedyskinesiainpatientswithschizophreniaduringantipsychotictreatment
AT yegdmitrieva clinicalandsocialriskfactorsoftardivedyskinesiainpatientswithschizophreniaduringantipsychotictreatment
AT yunborodyuk clinicalandsocialriskfactorsoftardivedyskinesiainpatientswithschizophreniaduringantipsychotictreatment
AT asboyko clinicalandsocialriskfactorsoftardivedyskinesiainpatientswithschizophreniaduringantipsychotictreatment